86T-28402-94818
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 335 / FL
- Registered
- 2021-05-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
9JT-15405-35338
Child or adolescent in my care · Female · 2022-08-02
Timeline
-
2021-05-14
Registered in v-safe
-
2021-05-14
Dose 1 — Pfizer-BioNTech
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-20
- 2021-05-21
- 2021-05-28
-
2021-06-04
Dose 2 — Pfizer-BioNTech
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-07-02
-
2021-07-11
Survey response — day 35, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Mild sore throat, some slight congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-16
Survey response — day 42, dose 2MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sinus infectionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-03
- 2021-12-05
-
2021-12-26
Dose 3 — Pfizer-BioNTech
-
2022-06-26
Survey response — 6 months, dose 3MedDRA: Exposure to SARS-CoV-2, Malaise, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Covid-related symptoms and exposure, but no positive testMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-14 | Pfizer-BioNTech | |
| 2 | 2021-06-04 | Pfizer-BioNTech | |
| 3 | 2021-12-26 | Pfizer-BioNTech | No |
Free text
Release 9 — day 35, dose 2
Symptoms: Mild sore throat, some slight congestion
Release 9 — day 42, dose 2
Symptoms: Sinus infection
Release 12 — 6 months, dose 3
Symptoms: Covid-related symptoms and exposure, but no positive test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release